Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.
Michael G. Motto, PhD
Advertisement
Michael G. Motto, PhD, is a director in the analytical research and development department at Pfizer Global Research and Development (Groton, CT).
Articles by Michael G. Motto, PhD
Advertisement
Latest Updated Articles
- Available Guidance and Best Practices for Conducting Forced Degradation Studies
Published: February 1st 2002 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
4
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
5
